CTLA4 and myeloid sarcoma: Her neurological symptoms were treated with several MS-targeting monoclonal antibodies and immunosuppressive therapies over the years, which were blamed for most of her other autoimmune features including interstitial lung disease, lymphocytic enterocolitis, and cytopenia, until finally a diagnosis of CTLA-4 insufficiency was made at the age of 24 years.